Anhui Anke Biotechnology (Group) is commendably using retain...
Anhui Anke Biotechnology (Group) is commendably using retained earnings for a strong ROE. Its robust net income growth suggests a promising future performance. The company's earnings growth rate is likely to maintain its current pace.
Is Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Latest Stock Performance Being Led By Its Strong Fundamentals?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment